The prevalence of infection by the hepatitis B (HBV) and C (HCV) viruses varies among geographical regions. We evaluated 263,795 blood donor samples collected from 1999-2001 in various cities in the state of Santa Catarina to determine the prevalence of HbsAg, anti-HBc and anti-HCV markers. The markers were analyzed by immunoenzymatic tests, as determined by the Ministry of Health, and the data were obtained from blood banks and from ANVISA (the Brazilian National Agency for Sanitary Vigilance). There was a significant reduction in the mean frequency of HbsAg and anti-HBc during the study period, from 0.98% to 0.64% and from 8.83% to 5.35%, respectively, though they varied considerably among the different regions. There was also a decrease ...
Little data are available on the seroprevalence of, and risk factors for hepatitis B and C viruses (...
BackgroundWe evaluate the current prevalence of serologic markers for hepatitis B virus (HBV) and he...
Little data are available on the seroprevalence of, and risk factors for hepatitis B and C viruses (...
The prevalence of infection by the hepatitis B (HBV) and C (HCV) viruses varies among geographical r...
Among 29833 donors evaluated we have found a prevalence of 1.52% for HBsAg and 11% for anti-HBc. The...
Hepatitis B and C continue to be important public health problems in Brazil. In this study, the prev...
Chronic viral hepatitis are main public health problems worldwide. Data about the seroprevalence to ...
Chronic viral hepatitis are main public health problems worldwide. Data about the seroprevalence to ...
Among 29833 donors evaluated we have found a prevalence of 1.52% for HBsAg and 11% for anti-HBc. The...
Background The aim of the present study was to estimate hepatitis B virus seroprevalence among first...
Em 29833 doadores pesquisados encontramos prevalência de 1,52% para o HBsAg e de 11% para o anti-HBc...
Background The aim of the present study was to estimate hepatitis B virus seroprevalence among firs...
BackgroundWe evaluate the current prevalence of serologic markers for hepatitis B virus (HBV) and he...
Hepatitis B and C constitute important public health problems worldwide. In Brazil, studies on preva...
Hepatitis B and C constitute important public health problems worldwide. In Brazil, studies on preva...
Little data are available on the seroprevalence of, and risk factors for hepatitis B and C viruses (...
BackgroundWe evaluate the current prevalence of serologic markers for hepatitis B virus (HBV) and he...
Little data are available on the seroprevalence of, and risk factors for hepatitis B and C viruses (...
The prevalence of infection by the hepatitis B (HBV) and C (HCV) viruses varies among geographical r...
Among 29833 donors evaluated we have found a prevalence of 1.52% for HBsAg and 11% for anti-HBc. The...
Hepatitis B and C continue to be important public health problems in Brazil. In this study, the prev...
Chronic viral hepatitis are main public health problems worldwide. Data about the seroprevalence to ...
Chronic viral hepatitis are main public health problems worldwide. Data about the seroprevalence to ...
Among 29833 donors evaluated we have found a prevalence of 1.52% for HBsAg and 11% for anti-HBc. The...
Background The aim of the present study was to estimate hepatitis B virus seroprevalence among first...
Em 29833 doadores pesquisados encontramos prevalência de 1,52% para o HBsAg e de 11% para o anti-HBc...
Background The aim of the present study was to estimate hepatitis B virus seroprevalence among firs...
BackgroundWe evaluate the current prevalence of serologic markers for hepatitis B virus (HBV) and he...
Hepatitis B and C constitute important public health problems worldwide. In Brazil, studies on preva...
Hepatitis B and C constitute important public health problems worldwide. In Brazil, studies on preva...
Little data are available on the seroprevalence of, and risk factors for hepatitis B and C viruses (...
BackgroundWe evaluate the current prevalence of serologic markers for hepatitis B virus (HBV) and he...
Little data are available on the seroprevalence of, and risk factors for hepatitis B and C viruses (...